RSS Feeds
Search

Press releases

Press releases

Displaying 1..5 of 5 - per page
Order by
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Ness Ziona ISRAEL, April 7, 2005 - Foamix Ltd., a leader in developing innovative topical delivery systems, enters new state-of-the-art facility. More
Jeffrey A. Niezgoda, M.D., F.A.C.E.P., and Eliot N. Mostow, M.D., M.P.H. announced interim analysis on the performance of HEALTHPOINT's innovative wound care product, OASIS Wound Matrix More
Jeffrey A. Niezgoda, M.D., F.A.C.E.P., and Eliot N. Mostow, M.D., M.P.H. announced interim analysis on the performance of HEALTHPOINT's innovative wound care product, OASIS Wound Matrix More
Displaying 1..5 of 5 - per page
Order by

Related Reports

Your selection

Industry sector
Drug delivery del
Topical del
Therapeutic target
Dermatological del
Ulcer, diabetic del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us